Stock news

ICICI Lombard Q1 FY27 Results: Net Profit Plummets 46% YoY to ₹403 Cr

The recent Q1 FY27 earnings release from ICICI Lombard General Insurance Co. Ltd. (NSE: ICICIGI) confirms the exact operational pain points mentioned in your snapshot, triggering a 17.7% single-day slump in share price down to ₹1,609.60.

Earnings Shock: What Went Wrong?

While top-line growth remained functional with Gross Written Premium (GWP) rising 10% year-on-year to ₹8,860 crore, the underwriting side took a massive beating from three specific, unexpected factors:

  1. The Supreme Court Motor Ruling: Triggered an immediate ₹165 crore increase in accident claim provisions.

  2. Large Fire Claims: Two isolated industrial fire claims stripped ₹63 crore directly out of profitability.

  3. Crop Provision Spikes: Unexpectedly high crop insurance provisions further strained margins.

This severe underwriting stress caused the company’s combined ratio—a vital insurance health metric measuring claims and expenses against earned premiums—to spike to 107.2% from 102.9% last year. Any figure over 100% signifies an underwriting loss. Consequently, net profit plummeted 46% YoY to ₹403 crore, vastly missing the market consensus estimate of ₹767 crore.

Technical & Options Strategy Framework

The earnings breakdown changes the playing field for derivative traders. The stock has plunged directly into its 52-week low territory (₹1,544.60), rendering near-term technical levels critical.

Strategy Playbook

Market Stance Technical Trigger Recommended Option Strategy Execution Note
Bearish Continuance If the price cracks the immediate ₹1,540–₹1,545 major support zone on heavy volume. Bear Put Spread or Protective Put Buy an In-the-Money (ITM) Put and sell an Out-of-the-Money (OTM) Put to cap premium costs while the combined ratio remains elevated.
Bullish Reversal Only if the stock stabilizes at support and begins to fill the ₹1,750–₹1,800 recent gap area. Bull Call Spread or Long Call Wait until heavy Open Interest (OI) Call writing near the old resistance unwinds, signaling that short sellers are covering.

Operational Insight: Despite the bottom-line carnage, ICICI Lombard’s balance sheet durability remains intact. Its solvency ratio actually improved marginally to 2.71x (well above the regulatory minimum of 1.50x). This means the plunge is driven by an earnings/margin shock rather than a capital crisis.

Post-Earnings Analyst Landscape

Brokerages are actively adjusting their expectations. While long-term systemic structural tailwinds (like India’s sub-5% insurance penetration) remain highly attractive, target prices are resetting. Prominent firms have trimmed their near-term targets to the ₹2,100–₹2,200 range (down from previous highs of ₹2,250+) to account for the margin compression.

Until comprehensive motor third-party tariff hikes are pushed through by regulators to offset this ongoing claims inflation, the stock is expected to undergo a base-building consolidation phase near these current lows

tirumedia

Recent Posts

Why ABB India Share Price Jumped 8% Today: Key Reasons Behind the Rally

ABB India surged over 8% today because investors focused on its long-term growth story rather…

1 week ago

Tata Power Ltd. Share Analysis 2026: Bullish & Bearish View, Fundamentals, Growth Outlook and 5-Year Price Target

[et_pb_section][et_pb_row][et_pb_column type="4_4"][et_pb_text] Tata Power – Building India's Energy Future Tata Power Ltd. is one of…

2 weeks ago

How to Pick Bullish or Bearish F&O Stocks Using Pre-Open Market Data

The 9:00 AM–9:08 AM pre-open session can provide useful clues about market sentiment, but it…

2 weeks ago

Adani Power Ltd – Bullish & Bearish Analysis Price Target

🟢 Bullish Analyst Opinions 1. India's Largest Private Thermal Power Producer Adani Power continues to…

2 weeks ago

Polycab India Ltd. – Detailed Bullish & Bearish Analyst Opinions with Price Target

Overall Analyst Consensus Consensus Rating: Buy Analysts Covering: 31 Buy: 22 Hold: 8 Sell: 1…

2 weeks ago

Biocon Ltd – bullish and bearish analyst opinions With Price Target

🟢 Bullish Factors 1. Global Biosimilars Leader Biocon is among the world's leading biosimilar manufacturers…

2 weeks ago